• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS IGG ANTIBODIES TO RUBELLA VIRUS; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS IGG ANTIBODIES TO RUBELLA VIRUS; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA Back to Search Results
Catalog Number 04618793190
Device Problem False Positive Result (1227)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/22/2015
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(4).(b)(6).
 
Event Description
The customer reported that they saw an implausible shift up in patient results when switching from igg antibodies to rubella virus (rubella igg) reagent lot number 182963 to lot number 185927.Monitoring the two affected patients over time revealed the up-shift of rubella igg values.The results for two patient samples were provided and results from reagent lot number 185927 were considered to be erroneous (falsely positive).The results for each patient were reported outside of the laboratory and each patient's physician questioned the up-shift in results.The first patient sample initially resulted as 9.15 iu/ml with reagent lot number 182963.The sample was repeated with reagent lot number 185927 and resulted as 15.99 iu/ml.The second patient sample initially resulted as 9.49 iu/ml with reagent lot number 182963.The sample was repeated with reagent lot number 185927 and resulted as 11.68 iu/ml.The sample was also repeated a second time with reagent lot number 185927 and resulted as 11.87 iu/ml.The patients were not adversely affected.The samples were tested on and e602 module analyzer serial number (b)(4).Control recovery for each lot number was found to be within expected ranges.
 
Manufacturer Narrative
Investigations of quality control release data have confirmed that recovery with kit lot 185927 is slightly higher when compared to kit lot 182963.However, the recovery is within specifications for both reagent lots.
 
Manufacturer Narrative
The investigation determined that samples with a concentration close to the cut-off may give different qualitative results, non-reactive versus reactive.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IGG ANTIBODIES TO RUBELLA VIRUS
Type of Device
ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key4996684
MDR Text Key23424232
Report Number1823260-2015-03958
Device Sequence Number1
Product Code LFX
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K072617
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Report Date 10/06/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number04618793190
Device Lot Number185927
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Event Location Laboratory
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/12/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-